Trial Design Webinars

  1. The Latest Generation Of Patient Recruitment Has Arrived 10/29/2025

    In the final session of our three-part webinar series, we explore what this next phase of evolution means for clinical trial planning and execution, and examine how innovative approaches are reshaping recruitment strategies from the ground up.

  2. Use Data For Fit-For-Purpose Patient Recruitment Strategy 10/29/2025

    Learn how a proactive, data-integrated approach can transform patient recruitment from a reactive hurdle into a built-in advantage — accelerating enrollment, improving representativeness, and setting studies up for success from day one.

  3. One Platform. Everything You Need. 10/28/2025

    By reaching more people, across more conditions, in half the time and cost, we make participant enrollment less of a barrier and more of a breakthrough.

  4. DCT Solutions That Successfully Deliver Results 10/28/2025

    Catch MRN COO, Todd McGrath, speaking on the impact DCT/hybrid trial design can have on overall trial success, noting that there is no "one-size-fits-all" — it takes a tailored approach to achieve maximum results.

  5. From Weeks To Days: An Innovative Approach To Patient Recruitment 10/28/2025

    Discover how AI-driven, personalized communication can break linguistic and literacy barriers to make patient recruitment faster, more inclusive, and 30% more effective.

  6. Clinical Leader Smart Sourcing Solutions Expo: Mural Health Removing Barriers To Trial Participation 10/28/2025

    Learn how one platform is transforming the participant journey to deliver a 60% reduction in participant drop-out and 97% engagement rates, improving retention for even the most vulnerable populations worldwide.

  7. Supplies Pain Points — Slow Enrollment 10/27/2025

    Without real-time visibility into enrollment rates, site performance, and supply levels, it becomes nearly impossible to proactively manage risk and optimize your trials.

  8. Fixing The Friction In Trial Enrollment: From Persuasion To Activation 10/20/2025

    Drawing on evidence from real-world trials, this session will offer a practical roadmap for transforming a patient’s “no” into an informed and empowered “yes.” It’s not about persuading harder; it’s about designing smarter.

  9. No Statistically Significant Progress — Yet 10/20/2025

    Dr. Jennifer E. Miller of the Yale School of Medicine says her Good Pharma Scorecard found no statistically significant diversity improvements in oncology trials over the past decade, despite decades of policy efforts and major investments.

  10. Community Trust Can't Be Outsourced 10/20/2025

    Dr. Brescher underscores that authentic community trust can’t come from corporate messaging alone. It grows when people from within the community lead research conversations and build relationships grounded in shared experience.